Trial Profile
A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Oct 2010
Price :
$35
*
At a glance
- Drugs Dasabuvir (Primary) ; Ketoconazole
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Abbott Laboratories
- 26 Apr 2009 Pharmacokinetc results reported at the 44th Annual Meeting of the European Association for the Study of the Liver.
- 04 Mar 2009 Actual patient number changed from 36 to 45 as reported by ClinicalTrials.gov.
- 04 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.